Ministerio DA Saude/ Pharmaceutical Import Profile — Mozambique (DGFT 2022–2026)

Name: Ministerio DA Saude/ Pharmaceutical Import Records from India — 3 Products, $600.0K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Ministerio DA Saude/ — Pharmaceutical Importer Profile (2026) | 3 Products, $600.0K Trade | TransData Nexus

Ministerio DA Saude/

Pharmaceutical Importer · Mozambique · Antiviral & HIV Medications Focus · $600.0K Total Trade · DGFT Verified

Ministerio DA Saude/ is a pharmaceutical importer based in Mozambique with a total trade value of $600.0K across 3 products in 2 therapeutic categories. Based on 12 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. Ministerio DA Saude/ sources from 30 verified Indian suppliers, with Bharat Parenterals Limited accounting for 20.6% of imports.

Ministerio DA Saude/ — Import Portfolio & Supplier Network

Ministerio DA Saude/ import network — 3 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Ministerio DA Saude/?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Bharat Parenterals Limited	$4.2M	403	20.6%
Macleods Pharmaceuticals Limited	$2.7M	88	13.2%
Cipla Limited

What Formulations Does Ministerio DA Saude/ Import?

Formulation	Value	Ships
Dolutegravir as sodium + lamivudine	$880.7K	21
Midazolam injection,USP 50MG/10ML	$500.0K	10
Easy five tt vaccine dtwp-hepb-hib	$350.0K	7
Diptheria and tetanus(dt)/tetanus and	$300.0K	6
Paracetamol tablet BP 500MG unit Pack	$300.0K	6
Vaccine for human medicine [mixed vaccines for diptheria and tetanus] diphtheria& tetanus vaccine (adult) 10	$300.0K	6
Harmless medicines-artemether/lumefantri	$298.2K	6
Diptheria and tetanus (dt)/ tetanus anddiphtheria (td) adsorbed for adults andadolescents 5ML 10	$250.0K	5
Abacavir as sulfate and lamivudine dispersible tablets 120 MG / 60 MG	$226.1K	6
Pharmaceutical item umbigo gel 20GM 7 1 chlorhexidine digluconate 7 1 topicalgel 1 x 20 GM tube tax inv export	$205.5K	5
Abacavir sulfate 120MG + lamivudine 60MG	$200.0K	4
Paracetamol tablet BP 500MG unit Pack 1x 1000 TAB. in	$200.0K	4
Easy five tt vaccine dtwp-hepb-hib pentavalent vaccine Each vial of 0.5 ML contains 1 dose b/n.e5v013096	$200.0K	4
Material no. - 44032565 mb adult 360kitint (mfg licence no.: kd-390)	$200.0K	4
Drugs and pharmaceuticals harmless medicines rifampicin capsules BP 300 MG	$182.0K	4

Ministerio DA Saude/ imports 433 distinct pharmaceutical formulations. Showing top 15 by value. For full formulation-level data, contact TransData Nexus.

Import Portfolio — Top 3 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Dolutegravir	Antiviral & HIV Medications	$200.0K	4	0.0%	5
2	Tenofovir	Antiviral & HIV Medications	$200.0K	4	0.0%	5
3	Doxorubicin	Oncology	$200.0K	4	0.3%	16

Ministerio DA Saude/ imports 3 pharmaceutical products across 2 categories into Mozambique totaling $600.0K.

Ministerio DA Saude/ — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Ministerio DA Saude is the Ministry of Health of Mozambique, a government entity responsible for overseeing the country's healthcare system, including the procurement and distribution of pharmaceutical products. As a government procurement agency, it plays a pivotal role in sourcing and importing essential medicines to meet the public health needs of Mozambique. The Ministry operates under the jurisdiction of the Mozambican government, with its headquarters located in Maputo, the capital city. Its primary function is to ensure the availability and accessibility of quality healthcare services and products to the Mozambican population.

2Distribution Network

While specific details about Ministerio DA Saude's warehouse locations and logistics capabilities are not publicly disclosed, the Ministry is known to coordinate with various distribution channels to ensure the effective delivery of pharmaceutical products across Mozambique. This includes collaboration with public hospitals, clinics, and pharmacies to facilitate the nationwide distribution of imported medicines. The Ministry's distribution network is designed to cover both urban and rural areas, aiming to provide equitable access to healthcare services throughout the country.

3Industry Role

In Mozambique's pharmaceutical supply chain, Ministerio DA Saude functions as a central procurement agency. It is responsible for sourcing and importing pharmaceutical products, which are then distributed to public healthcare facilities and pharmacies. This role is crucial in ensuring that essential medicines are available to the population, particularly in the public sector. The Ministry's activities are guided by national health policies and regulations, aiming to maintain the quality and safety of pharmaceutical products within the country.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Ministerio DA Saude/

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Ministerio DA Saude's sourcing strategy reveals a high concentration in its supplier base, with 30 unique Indian pharmaceutical companies identified as suppliers. The top five suppliers—Bharat Parenterals Limited, Macleods Pharmaceuticals Limited, Cipla Limited, Panacea Biotec Limited, and Mylan Laboratories Limited—account for a significant portion of the total import value. This concentration suggests a strategic approach to procurement, potentially leveraging established relationships and favorable terms with these suppliers. However, such dependency on a limited number of suppliers may pose risks related to supply chain disruptions or changes in supplier dynamics. The stability of these relationships is indicated by the consistent volume of shipments over the period, reflecting a reliable supply chain.

2Supply Chain Resilience

The resilience of Ministerio DA Saude's Indian supply chain appears robust, given the diversity of suppliers and the consistent volume of imports. The Ministry's sourcing strategy includes a range of pharmaceutical formulations, indicating a diversified product portfolio. While specific details about backup suppliers and shipping routes are not publicly available, the Ministry's established relationships with multiple suppliers suggest a level of preparedness to mitigate potential disruptions. Additionally, the regulatory compliance of key suppliers, such as adherence to Good Manufacturing Practices (GMP), is essential to ensure the quality and safety of imported medicines.

Importing Pharmaceuticals into Mozambique — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Mozambique

1Regulatory Authority & Framework

The regulation of pharmaceutical products in Mozambique is overseen by the Autoridade Nacional Reguladora de Medicamentos de Moçambique (ANARME), established under the Medicines Act of 2017. ANARME is responsible for ensuring the quality, safety, efficacy, and traceability of all pharmaceutical products circulating in the country. Before ANARME's establishment, regulatory responsibilities were managed by the National Directorate of Pharmacy (DNF) under the Ministry of Health. The legal framework governing pharmaceutical imports includes Law No. 12/2017, which establishes rules for the production, distribution, use, and availability of medicines, vaccines, biological, and health products. This law aims to ensure that medicines in Mozambique are safe, effective, of good quality, and meet the needs of the population.

2Import Licensing & GMP

Importers of pharmaceutical products in Mozambique must be licensed by the Ministry of Industry and Commerce. The licensing process requires compliance with specific conditions, including the recruitment of a qualified technical manager with the necessary qualifications and techno-professional profile approved by the Ministry of Health. Additionally, importers must provide a valid Good Manufacturing Practice (GMP) certificate for each manufacturing site, demonstrating compliance with WHO GMP standards or other equivalent systems. The GMP certificate must be specific to the site and issued within the last two years by the ANARME inspection authority or by entities officially recognized by ANARME. Product labels must state "manufactured in" followed by the actual manufacturing site, as contract manufacturing arrangements are not permitted under any circumstances.

Ministerio DA Saude/ — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Ministerio DA Saude's product category focus on Antiviral & HIV Medications (66.7%) and Oncology (33.3%) aligns with the pressing public health needs in Mozambique. The high import value of Dolutegravir and Tenofovir, both essential in HIV treatment, reflects the Ministry's commitment to addressing the HIV/AIDS epidemic. The inclusion of Doxorubicin, a critical chemotherapy agent, indicates a strategic approach to managing cancer care. These therapeutic areas are prioritized to meet the significant health challenges faced by the Mozambican population.

2Sourcing Profile

Ministerio DA Saude's sourcing strategy emphasizes the procurement of generic drugs, particularly from Indian manufacturers, to ensure cost-effective access to essential medicines. The Ministry's preference for finished pharmaceutical formulations, such as tablets, capsules, syrups, and injections, aligns with the immediate healthcare needs of the population. India's established pharmaceutical industry, known for its adherence to international quality standards, makes it a preferred sourcing partner for the Ministry.

3Market Positioning

Seller's Guide — How to Become a Supplier to Ministerio DA Saude/

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to enter the Mozambican market by aligning with Ministerio DA Saude's procurement needs. Potential gaps in the Ministry's current sourcing include the need for additional suppliers to diversify the supply chain and mitigate risks associated with over-reliance on a limited number of suppliers. Indian exporters can explore these opportunities by ensuring compliance with Mozambique's regulatory requirements and demonstrating the quality and efficacy of their products.

2Requirements & Qualifications

Indian exporters aiming to supply pharmaceutical products to Ministerio DA Saude must obtain a valid GMP certificate for each manufacturing site, demonstrating compliance with WHO GMP standards or other equivalent systems. Product labels must state "manufactured in" followed by the actual manufacturing site, as contract manufacturing arrangements are not permitted. Additionally, exporters must ensure that their products are registered with ANARME and comply with all labeling and serialization requirements set by Mozambican authorities.

3How to Approach

Frequently Asked Questions — Ministerio DA Saude/

What products does Ministerio DA Saude/ import from India?

Ministerio DA Saude/ imports 3 pharmaceutical products across 2 categories. Top imports: Dolutegravir ($200.0K), Tenofovir ($200.0K), Doxorubicin ($200.0K).

Who supplies pharmaceuticals to Ministerio DA Saude/ from India?

Ministerio DA Saude/ sources from 30 verified Indian suppliers. The primary supplier is Bharat Parenterals Limited (20.6% of imports, $4.2M).

What is Ministerio DA Saude/'s total pharmaceutical import value?

Ministerio DA Saude/'s total pharmaceutical import value from India is $600.0K, based on 12 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Ministerio DA Saude/ focus on?

Ministerio DA Saude/ imports across 2 categories. The largest: Antiviral & HIV Medications (66.7%), Oncology (33.3%).

Get Full Ministerio DA Saude/ Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Profile aggregates 2 company name variants from customs records. For current shipment-level data, contact TransData Nexus.